Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: A randomized trial

Annals of Internal Medicine

Volumn 146, Issue 9, 2007, Pages 631-639

  Salvarani, Carlo ^a   Macchioni, Pierluigi ^a   Manzini, Carlo ^b   Paolazzi, Giuseppe ^c   Trotta, Aldo ^d   Manganelli, Paolo ^e   Cimmino, Marco ^f   Gerli, Roberto ^g   Catanoso, Maria Grazia ^a   Boiardi, Luigi ^a   Cantini, Fabrizio ^h   Klersy, Catherine ⁱ   Hunder, Gene G ^j  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c SANTA CHIARA HOSPITAL   (Italy)

^d Policlinico S Salvatore   (Italy)

^e MAGGIORE HOSPITAL   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g POLICLINICO MONTELUCE   (Italy)

^h MISERICORDIA E DOLCE HOSPITAL   (Italy)

ⁱ FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^j MAYO CLINIC COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; PREDNISONE; ANTIRHEUMATIC AGENT; GLUCOCORTICOID; MONOCLONAL ANTIBODY; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BLADDER CANCER; CATARACT; CHOLECYSTITIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DYSPEPSIA; FEMALE; FOLLOW UP; GIANT CELL ARTERITIS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INFECTION; INJECTION SITE REACTION; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANCREATITIS; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RELAPSE; RHEUMATIC POLYMYALGIA; SENSITIVITY ANALYSIS; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; DRUG ANTAGONISM; DRUG COMBINATION; MIDDLE AGED; REMISSION;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PLACEBOS; POLYMYALGIA RHEUMATICA; PREDNISONE; RECURRENCE; REMISSION INDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34248375722     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-146-9-200705010-00005     Document Type: Article

References (32)